Since proteosome ubiquitination and degradation are essential steps in response to HSP90 inhibition, this alteration could be the result of a differential reaction in the KRAS-mutated and TN groups compared to the other lung adenocarcinoma molecular subgroups. This evidence concerns the gene HSP90AA1 and lung adenocarcinoma.